Filing Details
Dermata Therapeutics, Inc. (NASDAQ:DRMA) filed a Form 8-K with the Securities and Exchange Commission on August 05, 2026, disclosing a material event.
8k filedNASDAQ:DRMA
Dermata Therapeutics, Inc. (DRMA) Reports Material Event to SEC
Filing Details Dermata Therapeutics, Inc. (NASDAQ:DRMA) filed a Form 8-K with the Securities and Exchange Commission on August 05, 2026, disclosing a material event. Market…
Market Context
Dermata Therapeutics, Inc.'s stock currently trades at $1.17 with a market capitalization of $1.9M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Dermata Therapeutics, Inc.'s stock.
All SEC filings for Dermata Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View DRMA Stock Page
Frequently Asked Questions
Where can I read DRMA's SEC filings?
Browse all filings on our DRMA SEC filings page.
What types of SEC filings does Dermata Therapeutics, Inc. file?
Public companies like Dermata Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.